EUVIMEDEUVIMED entdecken
Open Access

Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis

Erica Dalla, Michael Papanicolaou, Matthew D Park, Nicole Barth, Rui Hou, Deisy Segura-Villalobos, Luis Valencia Salazar, Dan Sun, Alistair R R Forrest, Maria Casanova-Acebes, David Entenberg, Miriam Merad und 1 weitere

Cell · 2024-11 · 187 (23) · 6631-6648.e20

DOI: 10.1016/j.cell.2024.09.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2024-11. Verfasst von Erica Dalla und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Black Family Stem Cell Institute, Icahn School of Medic…. Hauptthemen laut MEDLINE: Macrophages, Alveolar, Breast Neoplasms, Lung Neoplasms, Transforming Growth Factor beta2. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast disseminated cancer cells (DCCs) can remain dormant in the lungs for extended periods, but the mechanisms limiting their expansion are not well understood. Research indicates that tissue-resident alveolar macrophages suppress breast cancer metastasis in lung alveoli by inducing dormancy. Through ligand-receptor mapping and intravital imaging, it was found that alveolar macrophages express transforming growth factor (TGF)-β2. This expression, along with persistent macrophage-cancer cell interactions via the TGF-βRIII receptor, maintains cancer cells in a dormant state. Depleting alveolar macrophages or losing the TGF-β2 receptor in cancer cells triggers metastatic awakening. Aggressive breast cancer cells are either suppressed by alveolar macrophages or evade this suppression by avoiding interaction and downregulating the TGF-β2 receptor. Restoring TGF-βRIII in aggressive cells reinstates TGF-β2-mediated macrophage growth suppression. Thus, alveolar macrophages act as a metastasis immune barrier, and downregulation of TGF-β2 signaling allows cancer cells to overcome macrophage-mediated growth suppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophages, AlveolarBreast NeoplasmsLung NeoplasmsTransforming Growth Factor beta2AnimalsFemaleMiceHumansCell Line, TumorReceptor, Transforming Growth Factor-beta Type IINeoplasm MetastasisReceptors, Transforming Growth Factor betaSignal TransductionLung

Stichwörter der Autor:innen

TGFβ2TGFβR3alveolar macrophagebreast cancerdormancyhomeostasisintravital imaginglung metastasisreawakening

Substanzen

Transforming Growth Factor beta2Receptor, Transforming Growth Factor-beta Type IIReceptors, Transforming Growth Factor beta

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological Scien…
  • Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Cancer Dormancy Institute, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Montefiore Einstein Compre…
  • Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Cancer Dormancy Institute, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Gruss…
  • Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia.
  • Cancer Immunity Laboratory, Molecular Oncology Program, Spanish National Cancer Centre, Madrid, Spain.

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • NCCIH NIH HHS
  • Wellcome Trust
  • National Health and Medical Research Council
  • The Mark Foundation for Cancer Research

Zitieren

APA

Dalla, E., Papanicolaou, M., Park, M. D., Barth, N., Hou, R., Segura-Villalobos, D., Valencia Salazar, L., Sun, D., Forrest, A. R. R., Casanova-Acebes, M., Entenberg, D., Merad, M., & Aguirre-Ghiso, J. A. (2024). Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis. Cell, 187(23), 6631-6648.e20. https://doi.org/10.1016/j.cell.2024.09.016

Vancouver

Dalla E, Papanicolaou M, Park MD, Barth N, Hou R, Segura-Villalobos D, et al. Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis. Cell. 2024;187(23):6631-6648.e20. doi:10.1016/j.cell.2024.09.016

BibTeX
@article{Dalla2024,
  author = {Dalla, Erica and Papanicolaou, Michael and Park, Matthew D and Barth, Nicole and Hou, Rui and Segura-Villalobos, Deisy and Valencia Salazar, Luis and Sun, Dan and Forrest, Alistair R R and Casanova-Acebes, Maria and Entenberg, David and Merad, Miriam and Aguirre-Ghiso, Julio A},
  title = {Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {23},
  pages = {6631--6648.e20},
  doi = {10.1016/j.cell.2024.09.016}
}
Kostenlos starten →